Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Saracatinib and Alcohol Drinking

Phase 2

Completed

Conditions: Alcohol Drinking

Interventions: Drug: Placebos
Drug: Saracatinib

First Posted Date: 2016-11-04

Last Posted Date: 2020-11-13

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT02955186

Locations: 🇺🇸
CMHC, Substance Abuse Center, New Haven, Connecticut, United States

Stage III Community-based Efficacy Trial for Mothering From the Inside Out

Not Applicable

Completed

Conditions: Parenteral Drug Abuse
Parents
Addiction
Substance Abuse Drug Chronic
Child Neglect
Child Neglect Emotional
Child Abuse
Parent-Child Problem
Parent-Child Relations
Parent / Child Problem

Interventions: Behavioral: Mothering From the Inside Out (MIO)
Behavioral: Parent Education

First Posted Date: 2016-11-04

Last Posted Date: 2021-07-14

Lead Sponsor: Yale University

Target Recruit Count: 97

Registration Number: NCT02955199

Locations: 🇺🇸
The Moms 'n' Kids Program at the APT Foundation, New Haven, Connecticut, United States

Mindfulness - Based Stress Reduction and the Relationship on Inflammation in Autoimmune Hepatitis

Not Applicable

Completed

Conditions: Autoimmune Hepatitis

Interventions: Behavioral: mindfulness based stress reduction

First Posted Date: 2016-10-31

Last Posted Date: 2020-07-02

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT02950077

Locations: 🇺🇸
Yale Liver Center, New Haven, Connecticut, United States

Glycemic Index of Commonly Consumed Sweeteners

Not Applicable

Terminated

Conditions: Healthy

Interventions: Other: Glucose50
Other: Glucose100
Other: Glucose42
Other: Oral Glucose Tolerance Test

First Posted Date: 2016-10-13

Last Posted Date: 2019-11-26

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT02931578

Locations: 🇺🇸
Yale Center for Clinical Investigation Church Street Research Unit, New Haven, Connecticut, United States

A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk

Not Applicable

Completed

Conditions: HIV
Acquired Immunodeficiency Syndrome

Interventions: Behavioral: ESTEEM
Behavioral: CMHT
Behavioral: VCT

First Posted Date: 2016-10-10

Last Posted Date: 2022-10-18

Lead Sponsor: Yale University

Target Recruit Count: 254

Registration Number: NCT02929069

Locations: 🇺🇸
Clinical Research Building, University of Miami, Miami, Florida, United States
🇺🇸
School of Public Health, Yale University, New Haven, Connecticut, United States

A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists

Completed

Conditions: Eczema
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Genetic Disease, Inborn
Skin Diseases, Eczematous
Dermatitis, Atopic
Skin Diseases
Skin Diseases, Genetic
Dermatitis

Interventions: Other: Care provided by general pediatrician
Other: Care provided by pediatric dermatologist

First Posted Date: 2016-09-28

Last Posted Date: 2018-01-11

Lead Sponsor: Yale University

Target Recruit Count: 26

Registration Number: NCT02916888

Locations: 🇺🇸
Yale Dermatology Associates, New Haven, Connecticut, United States

Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability

Not Applicable

Conditions: Intellectual Disability
Autism

Interventions: Behavioral: Cognitive-Behavioral Therapy
Other: Functional magnetic resonance imaging (fMRI)

First Posted Date: 2016-09-26

Last Posted Date: 2025-02-03

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT02914951

Locations: 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures

Phase 4

Terminated

Conditions: Hip Fractures
Blood Loss

Interventions: Drug: Placebo
Drug: Tranexamic Acid

First Posted Date: 2016-09-21

Last Posted Date: 2019-07-29

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT02908516

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Sleep, Coping and Executive Functioning in Youth With Type 1 Diabetes

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Other: No intervention

First Posted Date: 2016-09-21

Last Posted Date: 2018-07-02

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT02908555

Locations: 🇺🇸
Yale School of Nursing, West Haven, Connecticut, United States

Randomized Phase II Trial of Chemoembolization and Sorafenib

Phase 2

Withdrawn

Conditions: Hepatocellular Carcinoma

Interventions: Drug: conventional TACE in combination with sorafenib, administered on a continuous schedule
Drug: conventional TACE in combination with sorafenib, administered on a sequential schedule

First Posted Date: 2016-09-20

Last Posted Date: 2018-01-10

Lead Sponsor: Yale University

Registration Number: NCT02908165

Locations: 🇺🇸
Smilow Cancer Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy